In vitro procoagulant and anticoagulant properties of Naja naja naja venom

Toxicon

Volumn 42, Issue 3, 2003, Pages 239-247

  Sundell, I B ^a,e   Ranby M ^b   Zuzel, M ^a   Robinson, K A ^c   Theakston, R D G ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c Amer Cardiovasc Research Institute   (United States)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e PUGET SOUND BLOOD CENTER   (United States)

Author keywords

Blood clotting; Naja naja naja venom; Platelets; Rheometry

Indexed keywords

CHROMOGENIC SUBSTRATE; FIBRIN; GLASS; PHOSPHOLIPASE A2; SNAKE VENOM; THROMBOPLASTIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOT RETRACTION; BLOOD CLOTTING; CELL CONTACT; CONTROLLED STUDY; ELASTICITY; FLOW MEASUREMENT; HEMODYNAMICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SNAKE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; TOXICITY;

NAJA; NAJA NAJA NAJA;

EID: 0242349156     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(03)00137-5     Document Type: Article

References (36)

1. 2 with anticoagulant activity. II. Inhibition of the phosholipid activity in coagulation. Biochem. Biophys. Acta. 429:1976;839-852.
2. Bohlin L., 1994. Method for measuring rheological properties and rheometer for carrying out the method. International patent Cooperation Treaty (PCT) patent WO 94/08222.
3. Carr M.E., Shen L.L., Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers. 16:1977;1-15.
4. Carr M.E., Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules. 11:1978;46-50.
5. Carr M.E. Jr, Martin E.J., Carr S.L. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation. Blood Coagul. Fibrinolysis. 13:2002;193-197.
6. Collet J., Soria J., Mirshahi M., Hirsch M., Dagonnet F.B., Caen J., Soria C. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood. 82:1993;2462-2469.
7. Collet J.P., Montalescot G., Lesty C., Soria J., Mishal Z., Thomas D., Soria C. Disaggregation of in vitro preformed platelet-rich clots by Abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler. Thromb. Vasc. Biol. 21:2001;142-148.
8. Gabriel D.A., Muga K., Boothrody E.M. The effect of fibrin structure on fibrinolysis. J. Biol. Chem. 267:1992;24259-24263.
9. Gao R., Kini M., Gopalakrishnakone P. A novel prothrombin activator from the venom of Micropechis ikaheka: isolation and characterization. Arch. Biochem. Biophys. 408:2002;87-92.
10. 2. Proc. Natl. Acad. Sci. USA. 94:1997;7845-7850.
11. Hansson K.M., Tengvall P., Lundström I., Rånby M., Lindahl T.L. Comparative studies with surface plasmon resonance and free oscillation rheolmetry on inhibition of platelets with cytochalasin E and monoclonal antibodies towards GPIIb/IIIa. Biosens. Bioelectron. 2001.
12. 2 purified from Heloderma horridum (beaded lizard) venom. Biochem. Biophys. Acta. 1211:1994;61-68.
13. 2 platelet inhibitor. Toxicon. 32:1994;915-925.
14. 2. Toxicon. 33:1995;275.
15. 2 from the venom of the Papuan black snake (Pseudechis papuanus). Biochim. Biophys. Acta. 1250:1995;137-143.
16. Lee W.-H., Zhang Y., Wang W.-Y., Xiong Y.-L., Gao R. Isolation and properties of a blood coagulation factor X activator from the venom of king cobra (Ophiophagus hannah). Toxicon. 33:1995;1263-1276.
17. Li Q.-B., Yu Q.-S., Huang G.-W., Tokeshi Y., Nakamura M., Kinjoh K., Kosugi T. Hemostatic disturbances observed in patients with snakebite in south China. Toxicon. 38:2000;1355-1366.
18. 2 by quercetin. Inflammation. 17:1993;573-582.
19. Niewiarowski S., Regoeczi E., Stewart G.J., Senyi A.F., Mustard J.E. Platelet interaction with polymerizing fibrin. J. Clin. Invest. 51:1972;685-700.
20. Okada M., Blombäck B. Factors influencing fibrin gel structure studied by flow measurement. Ann. NY. Acad. Sci. 408:1983;233-253.
21. Ramström S., Rånby M., Lindahl T.L. Iso-citrate is a more gentle anticoagulant than citrate. Thromb. Haemost. 82:1999;292-293.
22. Rånby M., Gustavsson K.M., Lindahl T.L. Laboratory diagnosis of thrombophilia by endothelial cell modulated coagulation. Blood Coagul. Fibrinol. 10:1999;173-179.
23. Rao V.S., Kini R.M., Pseurtarin C. a prothrombin activator from Pseudonaja textilis venom: its structural and functional similarity to mammalian coagulation factor Xa-Va complex. Biochem. J. 369:2002;129-139.
24. Rao V.S., Joseph J.S., Kini R.M. Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa. Biochem. J. 369:2003;635-642.
25. Reid H.A. Cobra Bites. Br. Med. J. 2:1964;540.
26. 2 activity and arachidonate metabolism on human neutrophils. Biochem. Biophys. Acta. 1001:1989;1-8.
27. 2 inhibitors aristolochic acid and PGBx on A23187-stimulated mobilization of arachidonate in human neutrophils are overcome by diacylglycerol or phorbol ester. Biochem. Biophys. Acta. 1126:1992;319-326.
28. Rudrammaji L.M., Machiah, Kantha T.P., Gowda T.V. Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom. Mol. Cell Biochem. 219:2001;39-44.
29. Shafqat J., Siddiqi A.R., Zaidi Z.H., Jornvall H. Extensive multiplicity of the miscellaneous type of neurotoxin from the venom of the cobra Naja naja naja and structural characterization of major components. FEBS Lett. 284:1991;70-72.
30. Stueven H., Aprahamian C., Thomson B., Horowitz L., Darin J. Cobra envenomation: an uncommon emergency. Ann. Emerg. Med. 12:1983;79.
31. Sundell I.B., Theakston R.D.G., Kamiguti A.S., Harris R.J., Treweeke A.T., Laing G.D., Fox J.W., Warrell D.A., Zuzel M. The inhibition of platelet aggregation and blood coagulation by Micropechis ikaheka venom. Br. J. Haematol. 114:2001;852-860.
32. Theakston R.D.G., Phillips R.E., Warrell D.A., Galagedera Y., Abeysekera D.T.D.J., Dissanayaka P., de Silva A., Aloysius D.J. Envenoming by the common krite (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans. R. Soc. Trop. Med. Hyg. 84:1990;301-308.
33. 2. Eur. J. Biochem. 112:1980;25-32.
34. 2 enzymes from Habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon. 25:1987;501-515.
35. 2: its effect on enzymatic and pathological activities. Toxicon. 25:1987;929-937.
36. 2 from Vipera russelli venom with aristolochic acid: a circular dichroism study. Toxicon. 25:1987;939-946.